Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat

Neuroendocrinology

Volumn 63, Issue 3, 1996, Pages 269-274

  Uvnäs Moberg, Kerstin ^a   Ahlenius, Sven ^b   Alster, Pawel ^a   Hillegaart, Viveka ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Astra Arcus AB   (Sweden)

Author keywords

Catecholamine receptors; Glucagon; Glucose; Insulin; Serotonin receptors

Indexed keywords

1 (3 CHLOROPHENYL)BIGUANIDE; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLUCAGON; GLUCOSE; INSULIN; PINDOLOL; QUINPIROLE; RACLOPRIDE; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ARTICLE; DOPAMINERGIC SYSTEM; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BLOOD GLUCOSE; BROMOCRIPTINE; BUSPIRONE; DOPAMINE AGONISTS; ERGOLINES; GLUCAGON; INSULIN; MALE; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGONISTS; TETRAHYDRONAPHTHALENES;

EID: 0030044098     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000126970     Document Type: Article

References (15)

1. A receptors arc involved in the adrenaline-releasing cfTccls of 8-OH-DPAT in the conscious rat, Arch Pharmacol 1990:341: 381-384.
2. A receptor agonists buspirone and ipsapirone activate adrenaline release in the conscious rat, Eur J Pharmacol 1990:177: 107-110.
3. A and β2-adrenergic receptors mediate the hyperglycemic and hypoinsulinemic of Tects of 8-hy-droxy-2-(di-n-propylamino) tetralin in the conscious rat, J Pharmacol Exp Ther 1987:243: 1159-1166.
4. Chaoulof TF, Laude D, Baudrie V: Ganglionic transmission is a prerequisite for the adrenaline-releasing and hyperglycemic effects of 8-OH-DPAT, Eur J Pharmacol 1990:185:11-18.
5. Sailer CF, Kreamer LD: Glucose concentrations in brain and blood: Regulation by dopamine receptor subtypes, Brain Res 1991;546: 235-240.
6. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PA: VII, International Union of Pharmacology classification of receptors for 5-hydroxytryptaminc (serotonin), Pharmacol Rev 1994:46:157-203.
7. Gingrich JA, Caron MG: Recent advanced in the molecular biology of dopamine receptors, Annu Rev Neurosci 1993:16:299-321.
8. Kebabian JW, Neumcyer JL: The RBJ Handbook of Receptor Classification, Natick, Research Bioehemicals International, 1994.
9. Nilsson G, Uvnas-Wallensten K: Effect of teasing, sham feeding and feeding on plasma insulin concentrations in dogs; in: Radioimmunoassay: Methodology and Application in Physiology and in Clinical Studies, Stuttgart, Thieme, 1974, pp 91-97.
10. Faloona GR, Unger RH: Glucagon: in Jaffe BM, Bchrman HR(eds): Methods of Hormone Radioimmunoassay, New York, Academic Press, 1974, pp 317-330.
11. Chaoulof TF, Laude D, Baudrie V: Effects of the 5-HT1C/5-HT2 receptor agonists DOl and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat, Eur J Pharmacol 1990: 187:435-443.
12. Albinsson A, Palazidou E, Stephenson J, Andersson G: Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release, Eur J Pharmacol 1994;251: 157-161.
13. A and 5-HT2/5-HTk receptors induce oxytocin release in the male rat, Brain Res 1993,611: 330-332.
14. Buijs RM: Vasopressin and oxytocin: Their role in neuro-transmission, Pharmacol Ther 1983;22:127-141.
15. Siaud P, Puech R, Asscnmacher I, Alonso G: Microinjection of oxytocin into the dorsal vagal complex decreases pancreatic insulin secretion, Brain Res 1991:546:190-194.